Clinical trialNCT02642523WithdrawnEarly phase 1Interventional

Natriuretic Peptides and Metabolic Risk in Obesity

SponsorVanderbilt University Medical CenterEnrollment0HyperinsulinemiaObesity

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The investigators are examining: 1. the relationships of insulin levels and natriuretic peptide hormone levels, and 2. the effects of administering an infusion of natriuretic peptide hormone on the breakdown of fat in healthy lean and otherwise healthy obese individuals.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Katherine N Bachmann, MD
Vanderbilt Diabetes/Endocrinology
Study Director
clinicaltrials.gov ↗
Thomas J Wang, MD
Vanderbilt Cardiovascular Medicine
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

InsulinNesiritide

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: —
Primary completion: 28 Feb 2017
Completion: 28 Feb 2017
Last update posted: 6 Nov 2017
Registered enrollment: 0
Registry id: NCT02642523

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.